MARCHETTI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 1.981
EU - Europa 857
AS - Asia 200
AF - Africa 14
SA - Sud America 13
OC - Oceania 1
Totale 3.066
Nazione #
US - Stati Uniti d'America 1.962
IT - Italia 458
UA - Ucraina 100
IN - India 94
FI - Finlandia 75
FR - Francia 69
SE - Svezia 56
CN - Cina 51
SG - Singapore 46
GB - Regno Unito 31
BG - Bulgaria 27
IE - Irlanda 14
TG - Togo 13
AR - Argentina 12
CA - Canada 11
BE - Belgio 9
BZ - Belize 7
DE - Germania 6
ES - Italia 3
CH - Svizzera 2
HK - Hong Kong 2
RO - Romania 2
RU - Federazione Russa 2
TR - Turchia 2
UZ - Uzbekistan 2
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
CL - Cile 1
CZ - Repubblica Ceca 1
KZ - Kazakistan 1
MX - Messico 1
NL - Olanda 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 3.066
Città #
Fairfield 243
Rome 230
Ashburn 193
Chandler 170
Woodbridge 158
Ann Arbor 118
Houston 116
Seattle 90
Wilmington 87
Cambridge 81
Princeton 53
Fremont 45
Plano 45
Jacksonville 42
San Paolo di Civitate 41
Dearborn 32
Boston 31
Fiuggi 30
Helsinki 28
Lawrence 28
Sofia 27
Beijing 26
Washington 25
Andover 19
Millbury 18
San Diego 16
Taranto 14
Lomé 13
Federal 12
San Jose 12
Boardman 11
Dublin 11
Milan 11
Des Moines 10
Brussels 9
Norwalk 9
Phoenix 9
Singapore 9
Belize City 7
Hefei 5
Las Vegas 5
Mentana 5
Naples 5
Nanchang 4
Ottawa 4
Santa Marinella 4
Toronto 4
Albuquerque 3
Bühl 3
Centrale 3
Chilly-mazarin 3
Falls Church 3
Lappeenranta 3
Los Angeles 3
Madrid 3
Montespertoli 3
Southend 3
Tavarnuzze 3
Triggiano 3
Antea 2
Arzano 2
Bern 2
Chennai 2
Columbus 2
Fasano 2
Florence 2
Hong Kong 2
Indiana 2
Istanbul 2
Kunming 2
Latina 2
Laurel 2
Montreal 2
New York 2
Tashkent 2
Alatri 1
Atlanta 1
Auburn Hills 1
Bologna 1
Buffalo 1
Cachan 1
Cassino 1
Cava 1
Chengdu 1
Dhaka 1
Duncan 1
Groningen 1
Guangzhou 1
Gunzenhausen 1
Hebei 1
Henderson 1
Kilburn 1
Leawood 1
Leinì 1
London 1
Macerata 1
Melbourne 1
Mexico City 1
Miglianico 1
Montrouge 1
Totale 2.258
Nome #
SYNCRIP Modulates the Epithelial-Mesenchymal Transition in Hepatocytes and HCC Cells 177
Development of alkyl glycerone phosphate synthase inhibitors: Structure-activity relationship and effects on ether lipids and epithelial-mesenchymal transition in cancer cells 164
YAP integrates the regulatory Snail/HNF4α circuitry controlling epithelial/hepatocyte differentiation 151
TGFβ impairs HNF1α functional activity in Epithelial-to-Mesenchymal Transition interfering with the recruitment of CBP/p300 acetyltransferases 107
Modulating the Substrate Stiffness to Manipulate Differentiation of Resident Liver Stem Cells and to Improve the Differentiation State of Hepatocytes 100
Dynamic behaviour of hepatocyte is orchestrated by dynamic enrolment of HNF4-dependent activator and/or repressor complexes 93
TGFbeta induces binucleation/polyploidization in hepatocytes through a src-Dependent cytokinesis failure 87
Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis 86
Cooperative transformation of 32D cells by the combined expression of IRS-1 and V-Ha-Ras 82
p53 can inhibit cell proliferation through caspase-mediated cleavage of ERK2/MAPK 82
The homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser46 and mediates apoptosis 81
Expression of the beta4 integrin subunit induces monocytic differentiation of 32D/v-Abl cells 79
An epistatic mini-circuitry between the transcription factors Snail and HNF4a controls liver stem cell and hepatocyte features exhorting opposite regulation on stemness-inhibiting microRNAs 77
The stable repression of mesenchymal program is required for hepatocyte identity: A novel role for hepatocyte nuclear factor 4α 74
Molecular mechanisms controlling the phenotype and the EMT/MET dynamics of hepatocyte 73
New Tools for Molecular Therapy of Hepatocellular Carcinoma 73
Signaling networks controlling HCC onset and progression: influence of microenvironment and implications for cancer gene therapy 73
SYNCRIP modulates the epithelial-mesenchymal transition in hepatocytes and HCC Cells 73
Mechanisms controlling liver stem fate 69
Microenvironment and tumor cells: two targets for new molecular therapies of hepatocellular carcinoma. 69
Exogenous wt-p53 protein is active in transformed cells but not in their non-transformed counterparts: implications for cancer gene therapy without tumor targeting 69
Liver stem cell involvement in hepatic fibrosis onset and progression 64
Molecular Mechanisms controlling EMT/MET oscillations and hepatocyte differentiation of Resident Liver Stem Cells (RLSC) 60
Epithelial differentiation and liver zonation of hepatocyte imply coordinate Activation and repression of HNF4α target genes 54
Interference with p53 protein inhibits hematopoietic and muscle differentiation 53
“IDENTIFICATION OF HNF4 AS A NEW TARGET OF THE EMT INDUCING FACTOR SNAIL IN HEPATOCYTES” 51
Cooperative signaling between alpha6beta4 integrin and ErbB-2 receptor is required to promote phosphatidyl-3-kinase-dependent invasion 50
Activation of p53 function in carcinoma cells by the alpha6beta4 integrin. 50
TGFβ overrides HNF4α tumor suppressing activity through GSK3β inactivation: Implication for hepatocellular carcinoma gene therapy 49
“Molecular mechanism controlling TGFb-mediated Epithelial-to–Mesenchymal Transition in hepatocytes” 48
Exosome-Associated circRNAs as Key Regulators of EMT in Cancer 48
“MOLECULAR MECHANISMS CONTROLLING THE EPITHELIAL TO MESENCHYMAL TRANSITION IN HEPATOCYTES”. 46
Snail controls differentiation of hepatocytes by repressing HNF4 alpha expression 46
Genetica: un approccio molecolare 45
ERK5/MAPK is activated by TGFbeta in hepatocytes and required for the GSK-3beta-mediated Snail protein stabilization 43
p53 inhibits alpha6beta4 integrin signaling by promoting the caspase 3-dependent cleavage of AKT/PKB 41
HEPATOCYTE IDENTITY IMPLIES STABLE REPRESSION OF THE MESENCHYMAL PROGRAM: A NOVEL ROLE FOR HEPATOCYTE NUCLEAR FACTOR 4alpha 41
Analysis of the Myc and Max interaction with cI repressor-HLH domain fusions 39
Genetica: un approccio molecolare (V edizione) 39
Regulation of ERK5/MAPK activity by p53 38
TGFbeta overrides HNF4alpha tumor suppressing activity through GSK3beta inactivation: implication for gene therapy of HCC 33
p53 is involved in the differentiation but not in the differentiation-associated apoptosis of C2C12 myoblasts 32
Restoration of WT1/miR-769-5p axis by HDAC1 inhibition promotes MMT reversal in mesenchymal-like mesothelial cells 30
La cellula va in pensione. L'invecchiamento a livello dei tessuti 29
Snail regola il differenziamento epatocitario reprimendo trascrizionalmente HNF4. 29
The alpha 6 beta 4 integrin induces p53-dependent carcinoma cell apoptosis 27
Extracellular signal-Regulated Kinase 5 (ERK5) is required for the Yes-associated protein (YAP) co-transcriptional activity 26
Molecular players of EMT-MET transitions in hepatocytes: mechanisms and perspectives for tumor gene therapy 26
Induction of the neoplastic phenotype of EBV-established B lymphocytes by human Ha-ras oncogene 26
Ras oncogene transformation of human B lymphoblasts is associated with lymphocyte activation and with a block of differentiation 24
Snail controls both epithelial polarity and differentiation in hepatocytes. 23
Gli aspetti cellulari della senescenza 23
Cooperative signaling between alpha 6 beta 4 integrin and ErbB-2 receptor is required to promote PI3-Kinase-dependent invasion 17
The lncRNA HOTAIR: a pleiotropic regulator of epithelial cell plasticity 15
Totale 3.204
Categoria #
all - tutte 7.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 193
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.153


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019150 0 0 0 0 0 0 0 0 0 0 95 55
2019/2020667 87 23 11 39 55 133 91 73 65 48 33 9
2020/2021330 32 50 12 31 9 53 8 26 18 66 18 7
2021/2022643 5 26 51 10 64 11 11 108 65 87 102 103
2022/2023656 123 123 46 58 71 65 40 35 54 7 24 10
2023/2024370 14 42 34 37 41 96 22 38 1 35 10 0
Totale 3.204